Nanoparticle

  • Home
  • Dual-Action Therapy Targets Resistant Bacteria: Breakthrough with Nanocomposite Materials

Dual-Action Therapy Targets Resistant Bacteria: Breakthrough with Nanocomposite Materials

A recent study published in the Journal of Drug Delivery Science and Technology reveals a novel nanocomposite material that exhibits synergistic antibacterial and antibiofilm activities. Background: Challenges in Revolutionizing Antibacterial…

Rebuilding Bones: How DNA-Based Nanoparticles Could Transform Diabetic Osteoporosis Treatment

Background Diabetic osteoporosis (DOP) is a severe complication of diabetes that weakens bones, increasing the risk of fractures and other skeletal issues. Despite its prevalence, effective treatments for DOP remain…

New mRNA Vaccine Offers Hope for Lyme Disease Prevention

Background Lyme disease, caused by the bacterium Borrelia burgdorferi, remains the most common vector-borne illness in the United States. With approximately 476,000 cases diagnosed annually, it poses a growing public…

Breakthrough in Nanoparticle-Based Drug Delivery: A New Hope for Lung Cancer and COPD Treatment

Lung cancer (LC) and chronic obstructive pulmonary disease (COPD) remain among the leading causes of mortality worldwide, driven by factors such as smoking-induced inflammation, oxidative stress, and tissue remodeling. Despite…